| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.73B | 4.69B | 4.60B | 4.35B | 3.78B | 2.92B |
| Gross Profit | 1.32B | 1.27B | 1.18B | 1.40B | 1.13B | 875.46M |
| EBITDA | 1.22B | 1.18B | 1.16B | 1.17B | 913.93M | 371.69M |
| Net Income | 686.17M | 644.30M | 585.09M | 581.95M | 382.78M | -148.19M |
Balance Sheet | ||||||
| Total Assets | 8.81B | 8.17B | 8.30B | 7.76B | 7.04B | 5.67B |
| Cash, Cash Equivalents and Short-Term Investments | 655.23M | 601.75M | 630.85M | 483.29M | 578.96M | 601.99M |
| Total Debt | 2.35B | 2.20B | 2.26B | 2.21B | 1.54B | 853.75M |
| Total Liabilities | 3.55B | 3.43B | 3.40B | 3.36B | 2.66B | 1.64B |
| Stockholders Equity | 5.24B | 4.72B | 4.88B | 4.38B | 4.36B | 4.01B |
Cash Flow | ||||||
| Free Cash Flow | 506.58M | 534.22M | 570.04M | 71.33M | -635.76M | 317.07M |
| Operating Cash Flow | 1.20B | 1.15B | 1.28B | 782.29M | 401.09M | 864.57M |
| Investing Cash Flow | -795.81M | -690.00M | -772.89M | -1.22B | -1.03B | -574.52M |
| Financing Cash Flow | -119.48M | -467.17M | -359.69M | 379.45M | 579.93M | -339.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$12.65B | 15.71 | 13.83% | 1.57% | -13.95% | -13.61% | |
76 Outperform | HK$10.59B | 15.43 | 14.15% | 3.23% | 2.87% | 17.03% | |
74 Outperform | HK$10.97B | 9.62 | 14.64% | 8.66% | 28.34% | ― | |
65 Neutral | HK$7.92B | 12.74 | 7.29% | 2.50% | 11.18% | 46.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$4.71B | 13.72 | 17.97% | 2.25% | 14.32% | -19.44% | |
42 Neutral | HK$6.84B | -542.50 | -0.43% | ― | 7.11% | 77.53% |
Impro Precision Industries Limited has secured shareholder approval at an extraordinary general meeting held on 30 December 2025 to adopt a new share option scheme while terminating its existing scheme, following a poll vote in which approximately 97.9% of the votes cast were in favour. All 1,887,285,665 issued shares were eligible to vote with no restrictions or mandatory abstentions, and the resolution’s strong support, alongside full board attendance, underlines broad shareholder alignment on updating the company’s equity incentive framework, which is likely aimed at enhancing long-term alignment between management, employees and investors.
The most recent analyst rating on (HK:1286) stock is a Buy with a HK$7.49 price target. To see the full list of analyst forecasts on Impro Precision Industries Limited stock, see the HK:1286 Stock Forecast page.
Impro Precision Industries Limited has announced an Extraordinary General Meeting to be held on December 30, 2025, to consider the adoption of a New Share Option Scheme. This scheme aims to replace the existing one from 2018, subject to approval from the Stock Exchange. The new scheme is designed to enhance the company’s flexibility in granting share options, potentially impacting its operational strategy and shareholder value.
The most recent analyst rating on (HK:1286) stock is a Buy with a HK$7.49 price target. To see the full list of analyst forecasts on Impro Precision Industries Limited stock, see the HK:1286 Stock Forecast page.
Impro Precision Industries Limited reported a robust sales performance for the third quarter of 2025, with a notable 16.8% increase in revenue compared to the previous year. The company experienced significant growth in the diversified industrials and aerospace, medical, and energy segments, driven by strong demand in AI-related and medical end-markets. Despite challenges in the global economy, the company forecasts continued sales growth for the full year, although the automotive segment saw a decline.
The most recent analyst rating on (HK:1286) stock is a Buy with a HK$5.50 price target. To see the full list of analyst forecasts on Impro Precision Industries Limited stock, see the HK:1286 Stock Forecast page.
Impro Precision Industries Limited has announced its intention to terminate its Existing Share Option Scheme, which was adopted in June 2018, and replace it with a New Share Option Scheme. This move is in response to amendments in the Stock Exchange’s Listing Rules that came into effect in January 2023. The new scheme aims to align with market practices by offering incentives to eligible participants, enhancing enterprise value, and achieving long-term objectives for the company’s growth and development. The adoption of the new scheme is subject to shareholder approval and regulatory conditions.
The most recent analyst rating on (HK:1286) stock is a Buy with a HK$5.50 price target. To see the full list of analyst forecasts on Impro Precision Industries Limited stock, see the HK:1286 Stock Forecast page.